Browse studies

Find your next paid study

27,306 recruiting studies available now

A Proof-of-Concept Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of CSTI-500 in Participants With Prader-Willi Syndrome

This is a proof-of-concept, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of CSTI-500 in participants …

Prader-Willi Syndrome

Estimated

~$75 – $2,800

Actual pay is set by the research site.

ConSynance TherapeuticsNCT07348601

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Followed by an Open-Label Extension to Evaluate the Safety and Efficacy of Canvuparatide (MBX 2109) in Adult Patients With Hypoparathyroidism

The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants w…

Hypoparathyroidism

Estimated

~$50 – $2,100

Actual pay is set by the research site.

MBX BiosciencesNCT07699471

Phase 1

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer s Disease (AD) or Mild Cognitive Impairment (MCI)

Background: About 5 million adults in the United States have age-related brain disorders. These include Alzheimer disease (AD), mild cognitive impairment (MCI…

Alzheimer s DiseaseMild Cognitive ImpairmentHealthy

Estimated

~$500 – $6,750

Actual pay is set by the research site.

National Institute of Mental Health (NIMH)NCT07169630

Phase 2

Chemoimmunotherapy With Obinutuzumab, Ifosfamide, Carboplatin and Etoposide (O-ICE) in Children, Adolescents and Young Adults With Recurrent Refractory CD20+ Mature B-NHL

The purpose of this study is to determine the safety of administering obinutuzumab as a single agent alone and in combination with ifosfamide, carboplatin, and…

Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma+3 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

New York Medical CollegeNCT02393157

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1…

Crohn's Disease

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06430801

Evaluation of a Point-of-Care, AI-Powered Spectroscopy Device for Triage of Suspicious Vulvar Lesions: A Pilot Study

This purpose of this study is to assess the feasibility of using the DermaSensor™ device on vulvar skin.

Vulvar Intraepithelial Neoplasia, HPV-IndependentVulvar Squamous Cell CarcinomaVulvar Squamous Intraepithelial Lesion, HPV-Associated

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07886203

Phase 3

A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans

The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military…

Major Depression

Estimated

~$50 – $1,350

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT07226232

Observational

Can Financial Incentives Improve Medication Adherence and Patient Outcomes After Involuntary Hospitalization?

This study is a randomized controlled trial evaluating the impact of financial incentives on medication adherence among individuals with schizophrenia, schizoa…

Schizophrenia DisorderSchizoaffective DisorderBipolar Disorder (BD)+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Stanford UniversityNCT07130500

Phase 1

A Multicenter, Open Label, Non-randomized First-in-human Phase 1 Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of BAY 3547926 Alone, and in Combination, in Participants With Advanced Hepatocellular Carcinoma (HCC)

In this study, researchers want to learn about the safety of a new drug, BAY 3547926, and how well the drug works in people with a type of liver cancer called …

Hepatocellular Carcinoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BayerNCT06764316

Discovering Determinants of Food Intake by Application of Machine Learning to Complex, High-Dimensional Data

Background: Many people in the United States are overweight or obese. Researchers want to learn why some people can overeat and not gain weight, whereas other…

Healthy Volunteer

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT07637656

Observational

Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach

Variable outcomes after weight loss surgery are likely attributable to complex, poorly understood mechanisms. Due to the significant impact that morbid obesity…

Obesity, MorbidMetabolic SyndromeNASH - Nonalcoholic Steatohepatitis

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Missouri-ColumbiaNCT04841057

Women's Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH)

Background: Inequalities in COVID-19 infection, hospitalization, and death in under-studied, under-represented, and under-reported groups of people are severe…

Mental Health

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Environmental Health Sciences (NIEHS)NCT04983251